General anaesthetic agents do not influence persistent pain after breast cancer surgery: A prospective nationwide cohort study

European Journal of Anaesthesiology

Volumn 32, Issue 10, 2015, Pages 697-704

  Lefebvre Kuntz, Danièle ^a   Dualé, Christian ^b   Albi Feldzer, Aline ^c   Nougarède, Bertrand ^d   Falewee, Marie Noëlle ^e   Ouchchane, Lemlih ^b   Soule Sonneville, Sylvie ^b   Bonneau, Julie ^b   Dubray, Claude ^b   Schoeffler, Pierre ^b  

^a CENTRE OSCAR LAMBRET   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^c CENTRE RENÉ HUGUENIN   (France)

^d CENTRE JEAN PERRIN   (France)

^e CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; PROPOFOL;

ADULT; AGE; ALCOHOL ABUSE; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; DIABETES MELLITUS; FEMALE; GENERAL ANESTHESIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUMPECTOMY; MAJOR CLINICAL STUDY; NEUROPATHIC PAIN; OBSERVATIONAL STUDY; PARTIAL MASTECTOMY; PERIPHERAL NEUROPATHY; PERSISTENT POSTSURGICAL PAIN; POSTOPERATIVE PAIN; PROSPECTIVE STUDY; RISK FACTOR; SIMPLE MASTECTOMY; AGED; BREAST NEOPLASMS; COHORT ANALYSIS; MIDDLE AGED; MULTICENTER STUDY; NEURALGIA; PAIN, POSTOPERATIVE; PROCEDURES; QUESTIONNAIRE; TIME FACTOR; UNIVERSITY HOSPITAL;

ADULT; AGED; ANESTHESIA, GENERAL; ANESTHETICS, GENERAL; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MIDDLE AGED; NEURALGIA; PAIN, POSTOPERATIVE; PROPOFOL; PROSPECTIVE STUDIES; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; TIME FACTORS;

EID: 84973470883     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0000000000000215     Document Type: Article

References (54)

1. Crombie IK, Davies HT, Macrae WA. Cut and thrust: antecedent surgery and trauma among patients attending a chronic pain clinic. Pain 1998; 76:167-171.
2. Buvanendran A. Chronic postsurgical pain: are we closer to understanding the puzzle? Anesth Analg 2012; 115:231-232.
3. Haroutiunian S, Nikolajsen L, Finnerup NB, Jensen TS. The neuropathic component in persistent postsurgical pain: a systematic literature review. Pain 2013; 154:95-102.
4. Institut National du Cancer. Epidé miologie du cancer du sein en France mé tropolitaine-Donneés essentielles. http://lesdonnees.e-cancer.fr/lesfiches-de-synthese/1-types-cancer/9-cancer-sein/5-epidemiologie-ducancer-du-sein-en-france-metropolitaine-donnees-essentielles.html [Accessed 23 October 2014].
5. Jung BF, Ahrendt GM, Oaklander AL, Dworkin RH. Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain 2003; 104:1-13.
6. Vilholm OJ, Cold S, Rasmussen L, Sindrup SH. Sensory function and pain in a population of patients treated for breast cancer. Acta Anaesthesiol Scand 2009; 53:800-806.
7. Becker C, Pham DN, Assouad J, et al. Postmastectomy neuropathic pain: results of microsurgical lymph nodes transplantation. Breast 2008; 17:472-476.
8. Fassoulaki A, Triga A, Melemeni A, Sarantopoulos C. Multimodal analgesia with gabapentin and local anesthetics prevents acute and chronic pain after breast surgery for cancer. Anesth Analg 2005; 101:1427-1432.
9. Kairaluoma PM, Bachmann MS, Rosenberg PH, Pere PJ. Preincisional paravertebral block reduces the prevalence of chronic pain after breast surgery. Anesth Analg 2006; 103:703-708.
10. Cho AR, Kwon JY, Kim KH, et al. The effects of anesthetics on chronic pain after breast cancer surgery. Anesth Analg 2013; 116:685-693.
11. Dualé C, Ouchchane L, Schoeffler P, Dubray C. Neuropathic aspects of persistent postsurgical pain: a French multicenter survey with a 6-month prospective follow-up. J Pain 2014; 15:24.
12. Dualé C, Guastella V, Morand D, et al. Characteristics of the neuropathy induced by thoracotomy: a 4-month follow-up study with psychophysical examination. Clin J Pain 2011; 27:471-480.
13. Fassoulaki A, Patris K, Sarantopoulos C, Hogan Q. The analgesic effect of gabapentin and mexiletine after breast surgery for cancer. Anesth Analg 2002; 95:985-991.
14. Peintinger F, Reitsamer R, Stranzl H, Ralph G. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 2003; 89:648-652.
15. Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005; 114:29-36.
16. Bouhassira D, Lanteri-Minet M, Attal N, et al. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2008; 136:380-387.
17. Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004; 108:248-257.
18. Sullivan MJ, Bishop S, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assessment 1995; 7:524-532.
19. Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat 1985; 39:33-38.
20. Katz J, Clarke H, Seltzer Z. Review article: preventive analgesia: quo vadimus? Anesth Analg 2011; 113:1242-1253.
21. Kingston S, Mao L, Yang L, et al. Propofol inhibits phosphorylation of N-methyl-D-Aspartate receptor NR1 subunits in neurons. Anesthesiology 2006; 104:763-769.
22. Singler B, Troster A, Manering N, et al. Modulation of remifentanil-induced postinfusion hyperalgesia by propofol. Anesth Analg 2007; 104:1397-1403.
23. Bandschapp O, Filitz J, Ihmsen H, et al. Analgesic and antihyperalgesic properties of propofol in a human pain model. Anesthesiology 2010; 113:421-428.
24. Boccara G, Mann C, Pouzeratte Y, et al. Improved postoperative analgesia with isoflurane than with propofol anaesthesia. Can J Anaesth 1998; 45:839-842.
25. Cheng SS, Yeh J, Flood P. Anesthesia matters: patients anesthetized with propofol have less postoperative pain than those anesthetized with isoflurane. Anesth Analg 2008; 106:264-269.
26. Shin SW, Cho AR, Lee HJ, et al. Maintenance anaesthetics during remifentanil-based anaesthesia might affect postoperative pain control after breast cancer surgery. Br J Anaesth 2010; 105:661-667.
27. Tan T, Bhinder R, Carey M, Briggs L. Day-surgery patients anesthetized with propofol have less postoperative pain than those anesthetized with sevoflurane. Anesth Analg 2010; 111:83-85.
28. Li M, Mei W, Wang P, et al. Propofol reduces early postoperative pain after gynecological laparoscopy. Acta Anaesthesiol Scand 2012; 56:368-375.
29. Fassoulaki A, Melemeni A, Paraskeva A, et al. Postoperative pain and analgesic requirements after anesthesia with sevoflurane, desflurane or propofol. Anesth Analg 2008; 107:1715-1719.
30. Criswell HE, Ming Z, Pleasant N, et al. Macrokinetic analysis of blockade of NMDA-gated currents by substituted alcohols, alkanes and ethers. Brain Res 2004; 1015:107-113.
31. Richebé P, Rivalan B, Rivat C, et al. Effects of sevoflurane on carrageenanand fentanyl-induced pain hypersensitivity in Sprague-Dawley rats. Can J Anaesth 2009; 56:126-135.
32. Liu CR, Duan QZ, Wang W, et al. Effects of intrathecal isoflurane administration on nociception and Fos expression in the rat spinal cord. Eur J Anaesthesiol 2011; 28:112-119.
33. Dualé C, Sibaud F, Guastella V, et al. Perioperative ketamine does not prevent chronic pain after thoracotomy. Eur J Pain 2009; 13: 497-505.
34. Albi-Feldzer A, Mouret-Fourme EE, Hamouda S, et al. A double-blind randomized trial of wound and intercostal space infiltration with ropivacaine during breast cancer surgery: effects on chronic postoperative pain. Anesthesiology 2013; 118:318-326.
35. Takechi K, Carstens MI, Klein AH, Carstens E. The antinociceptive and antihyperalgesic effects of topical propofol on dorsal horn neurons in the rat. Anesth Analg 2013; 116:932-938.
36. Patel AJ, Honoré E, Lesage F, et al. Inhalational anesthetics activate twopore-domain background K+ channels. Nat Neurosci 1999; 2:422-426.
37. Lasarzik I, Winkelheide U, Stallmann S, et al. Assessment of postischemic neurogenesis in rats with cerebral ischemia and propofol anesthesia. Anesthesiology 2009; 110:529-537.
38. Kudo M, Aono M, Lee Y, et al. Effects of volatile anesthetics on N-methyl-Daspartate excitotoxicity in primary rat neuronal-glial cultures. Anesthesiology 2001; 95:756-765.
39. Corris R, Chou J, Riedel B, Collins M. Sevoflurane and its role in the development of chronic postsurgical pain: where is the smoking gun? Anesth Analg 2013; 117:1022.
40. Chan MT, Wan AC, Gin T, et al. Chronic postsurgical pain after nitrous oxide anesthesia. Pain 2011; 152:2514-2520.
41. Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain 2008; 24:479-496.
42. Chaparro LE, Smith SA, Moore RA, et al. Pharmacotherapy for the prevention of chronic pain after surgery in adults. Cochrane Database Syst Rev 2013; 7:CD008307.
43. Gärtner R, JensenMB, Nielsen J, et al. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA 2009; 302:1985-1992.
44. Mejdahl MK, Andersen KG, Gärtner R, et al. Persistent pain and sensory disturbances after treatment for breast cancer: six year nationwide followup study. BMJ 2013; 346:f1865.
45. Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008; 70:1630-1635.
46. Jud SM, Fasching PA, Maihofner C, et al. Pain perception and detailed visual pain mapping in breast cancer survivors. Breast Cancer Res Treat 2010; 119:105-110.
47. Steegers MA, Wolters B, Evers AW, et al. Effect of axillary lymph node dissection on prevalence and intensity of chronic and phantom pain after breast cancer surgery. J Pain 2008; 9:813-822.
48. Macdonald L, Bruce J, Scott NW, et al. Long-term follow-up of breast cancer survivors with postmastectomy pain syndrome. Br J Cancer 2005; 92:225-230.
49. Bishop SR, Warr D. Coping, catastrophizing and chronic pain in breast cancer. J Behav Med 2003; 26:265-281.
50. Andersen KG, Jensen MB, Kehlet H, et al. Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: cyclophosphamide, epirubicin and fluorouracil compared with docetaxel + epirubicin and cyclophosphamide. Acta Oncol 2012; 51:1036-1044.
51. Belfer I, Schreiber KL, Shaffer JR, et al. Persistent postmastectomy pain in breast cancer survivors: analysis of clinical, demographic, and psychosocial factors. J Pain 2013; 14:1185-1195.
52. Bruce J, Thornton AJ, Powell R, et al. Psychological, surgical, and sociodemographic predictors of pain outcomes after breast cancer surgery: a population-based cohort study. Pain 2014; 155:232-243.
53. Bergmann I, Gohner A, Crozier TA, et al. Surgical pleth index-guided remifentanil administration reduces remifentanil and propofol consumption and shortens recovery times in outpatient anaesthesia. Br J Anaesth 2013; 110:622-628.
54. Del Bianco P, Zavagno G, Burelli P, et al. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol 2008; 34:508-513.